BioCurity
A nanoparticle-based therapy that prevents healthy tissue damage due to radiation exposure for cancer patients receiving radiation therapy.
- Stage Product In Development
- Industry Biotechnology
- Location New Smyrna Beach, FL, USA
- Currency USD
- Founded October 2010
- Employees 2
Company Summary
BioCurity’s RadGuard™ prevents tissue damage from radiation exposure that is the norm in cancer radiation treatment and terrorist nuclear threats. RadGuard™ is unique in its ability to selectively protect healthy tissue from radiation damage while still allowing radiation treatments to attack cancerous tissue.Orlando Health has invested $100,000 and has transferred IP to BioCurity to commercialize this product.
Team
-
Cheryl BakerPresident
Advisors
-
Foley & LardnerLawyerUnconfirmedCraig Clayton, CPAAccountantUnconfirmed
Previous Investors
-
Orlando HealthUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.